United States

NanoCarrier Co Ltd (4571.T)

4571.T on Tokyo Stock Exchange

24 Nov 2017
Change (% chg)

¥2 (+0.29%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


NanoCarrier Co., Ltd. is a Japan-based biopharmaceutical products developer. The Company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It is engaged in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The... (more)


Beta: 2.57
Market Cap(Mil.): ¥29,332.38
Shares Outstanding(Mil.): 43.20
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 189.97 15.54
EPS (TTM): -- -- --
ROI: -- -10.87 11.80
ROE: -- -36.85 15.75

BRIEF-VBL Therapeutics and Nanocarrier signs agreement for VB-111 in Japan

* VBL Therapeutics and Nanocarrier Co Ltd sign exclusive agreement for VB-111 in Japan

Nov 06 2017

BRIEF-Nanocarrier signs exclusive agreement with VBL Therapeutics for VB-111 in Japan

* Says co signs an exclusive license agreement with VBL Therapeutics, for the development, commercialization, and supply of ofranergene obadenovec ("VB-111") in Japan

Nov 05 2017

BRIEF-NanoCarrier and JCR conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines

* Says it and NanoCarrier Co., Ltd conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines

Oct 09 2017

BRIEF-NanoCarrier says orphan drug designation of NC-6004 by the U.S. FDA

* Says NC-6004, which is under development in the U.S. for biliary cancer, has been granted to the orphan drug designation from the U.S. FDA (Food and Drug Administration)

Jul 31 2017

BRIEF-NanoCarrier receives orphan drug designation from FDA

* Says its micellar nanoparticles preparation NC-6300 for soft tissue sarcomas has been designated to orphan drug by Food and Drug Administration (FDA) in U.S.

Jul 18 2017

BRIEF- NanoCarrier announces licenses contract with Todai TLO

* Says it signed a license contract with Todai TLO Ltd, regarding NC-6300 related high polymer micelle DDS

Jun 15 2017

Earnings vs. Estimates